Global Niclosamide Market Insights and Forecast to 2028

Publisher Name :
Date: 24-Feb-2022
No. of pages: 90
Inquire Before Buying

Niclosamide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Niclosamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- 95% Niclosamide

- 96%-98% Niclosamide

- 99% Niclosamide

Segment by Application

- Feed

- Pesticide

- Pharmaceuticals

By Company

- Shanxi Hanjiang Pharmaceutical

- Zhengqing Pharmaceutical Group

- Prosperity Galaxy Chemical

- Anhui Topsun Pharmaceutical

- Chang Zhou Jialing Medicine Industry

- Suzhou Luosen Auxiliaries

- Anhui Sinotech Top Chemical

- Yabang Group

- Hangzhou Vanco Technology

Production by Region

- North America

- Europe

- China

- Japan

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Niclosamide Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Niclosamide Product Introduction
1.2 Market by Type
1.2.1 Global Niclosamide Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 95% Niclosamide
1.2.3 96%-98% Niclosamide
1.2.4 99% Niclosamide
1.3 Market by Application
1.3.1 Global Niclosamide Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Feed
1.3.3 Pesticide
1.3.4 Pharmaceuticals
1.4 Study Objectives
1.5 Years Considered
2 Global Niclosamide Production
2.1 Global Niclosamide Production Capacity (2017-2028)
2.2 Global Niclosamide Production by Region: 2017 VS 2021 VS 2028
2.3 Global Niclosamide Production by Region
2.3.1 Global Niclosamide Historic Production by Region (2017-2022)
2.3.2 Global Niclosamide Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Niclosamide Sales in Volume & Value Estimates and Forecasts
3.1 Global Niclosamide Sales Estimates and Forecasts 2017-2028
3.2 Global Niclosamide Revenue Estimates and Forecasts 2017-2028
3.3 Global Niclosamide Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Niclosamide Sales by Region
3.4.1 Global Niclosamide Sales by Region (2017-2022)
3.4.2 Global Sales Niclosamide by Region (2023-2028)
3.5 Global Niclosamide Revenue by Region
3.5.1 Global Niclosamide Revenue by Region (2017-2022)
3.5.2 Global Niclosamide Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Niclosamide Production Capacity by Manufacturers
4.2 Global Niclosamide Sales by Manufacturers
4.2.1 Global Niclosamide Sales by Manufacturers (2017-2022)
4.2.2 Global Niclosamide Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Niclosamide in 2021
4.3 Global Niclosamide Revenue by Manufacturers
4.3.1 Global Niclosamide Revenue by Manufacturers (2017-2022)
4.3.2 Global Niclosamide Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Niclosamide Revenue in 2021
4.4 Global Niclosamide Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Niclosamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Niclosamide Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Niclosamide Sales by Type
5.1.1 Global Niclosamide Historical Sales by Type (2017-2022)
5.1.2 Global Niclosamide Forecasted Sales by Type (2023-2028)
5.1.3 Global Niclosamide Sales Market Share by Type (2017-2028)
5.2 Global Niclosamide Revenue by Type
5.2.1 Global Niclosamide Historical Revenue by Type (2017-2022)
5.2.2 Global Niclosamide Forecasted Revenue by Type (2023-2028)
5.2.3 Global Niclosamide Revenue Market Share by Type (2017-2028)
5.3 Global Niclosamide Price by Type
5.3.1 Global Niclosamide Price by Type (2017-2022)
5.3.2 Global Niclosamide Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Niclosamide Sales by Application
6.1.1 Global Niclosamide Historical Sales by Application (2017-2022)
6.1.2 Global Niclosamide Forecasted Sales by Application (2023-2028)
6.1.3 Global Niclosamide Sales Market Share by Application (2017-2028)
6.2 Global Niclosamide Revenue by Application
6.2.1 Global Niclosamide Historical Revenue by Application (2017-2022)
6.2.2 Global Niclosamide Forecasted Revenue by Application (2023-2028)
6.2.3 Global Niclosamide Revenue Market Share by Application (2017-2028)
6.3 Global Niclosamide Price by Application
6.3.1 Global Niclosamide Price by Application (2017-2022)
6.3.2 Global Niclosamide Price Forecast by Application (2023-2028)
7 North America
7.1 North America Niclosamide Market Size by Type
7.1.1 North America Niclosamide Sales by Type (2017-2028)
7.1.2 North America Niclosamide Revenue by Type (2017-2028)
7.2 North America Niclosamide Market Size by Application
7.2.1 North America Niclosamide Sales by Application (2017-2028)
7.2.2 North America Niclosamide Revenue by Application (2017-2028)
7.3 North America Niclosamide Sales by Country
7.3.1 North America Niclosamide Sales by Country (2017-2028)
7.3.2 North America Niclosamide Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Niclosamide Market Size by Type
8.1.1 Europe Niclosamide Sales by Type (2017-2028)
8.1.2 Europe Niclosamide Revenue by Type (2017-2028)
8.2 Europe Niclosamide Market Size by Application
8.2.1 Europe Niclosamide Sales by Application (2017-2028)
8.2.2 Europe Niclosamide Revenue by Application (2017-2028)
8.3 Europe Niclosamide Sales by Country
8.3.1 Europe Niclosamide Sales by Country (2017-2028)
8.3.2 Europe Niclosamide Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Niclosamide Market Size by Type
9.1.1 Asia Pacific Niclosamide Sales by Type (2017-2028)
9.1.2 Asia Pacific Niclosamide Revenue by Type (2017-2028)
9.2 Asia Pacific Niclosamide Market Size by Application
9.2.1 Asia Pacific Niclosamide Sales by Application (2017-2028)
9.2.2 Asia Pacific Niclosamide Revenue by Application (2017-2028)
9.3 Asia Pacific Niclosamide Sales by Region
9.3.1 Asia Pacific Niclosamide Sales by Region (2017-2028)
9.3.2 Asia Pacific Niclosamide Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Niclosamide Market Size by Type
10.1.1 Latin America Niclosamide Sales by Type (2017-2028)
10.1.2 Latin America Niclosamide Revenue by Type (2017-2028)
10.2 Latin America Niclosamide Market Size by Application
10.2.1 Latin America Niclosamide Sales by Application (2017-2028)
10.2.2 Latin America Niclosamide Revenue by Application (2017-2028)
10.3 Latin America Niclosamide Sales by Country
10.3.1 Latin America Niclosamide Sales by Country (2017-2028)
10.3.2 Latin America Niclosamide Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Niclosamide Market Size by Type
11.1.1 Middle East and Africa Niclosamide Sales by Type (2017-2028)
11.1.2 Middle East and Africa Niclosamide Revenue by Type (2017-2028)
11.2 Middle East and Africa Niclosamide Market Size by Application
11.2.1 Middle East and Africa Niclosamide Sales by Application (2017-2028)
11.2.2 Middle East and Africa Niclosamide Revenue by Application (2017-2028)
11.3 Middle East and Africa Niclosamide Sales by Country
11.3.1 Middle East and Africa Niclosamide Sales by Country (2017-2028)
11.3.2 Middle East and Africa Niclosamide Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Shanxi Hanjiang Pharmaceutical
12.1.1 Shanxi Hanjiang Pharmaceutical Corporation Information
12.1.2 Shanxi Hanjiang Pharmaceutical Overview
12.1.3 Shanxi Hanjiang Pharmaceutical Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Shanxi Hanjiang Pharmaceutical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Shanxi Hanjiang Pharmaceutical Recent Developments
12.2 Zhengqing Pharmaceutical Group
12.2.1 Zhengqing Pharmaceutical Group Corporation Information
12.2.2 Zhengqing Pharmaceutical Group Overview
12.2.3 Zhengqing Pharmaceutical Group Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Zhengqing Pharmaceutical Group Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zhengqing Pharmaceutical Group Recent Developments
12.3 Prosperity Galaxy Chemical
12.3.1 Prosperity Galaxy Chemical Corporation Information
12.3.2 Prosperity Galaxy Chemical Overview
12.3.3 Prosperity Galaxy Chemical Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Prosperity Galaxy Chemical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Prosperity Galaxy Chemical Recent Developments
12.4 Anhui Topsun Pharmaceutical
12.4.1 Anhui Topsun Pharmaceutical Corporation Information
12.4.2 Anhui Topsun Pharmaceutical Overview
12.4.3 Anhui Topsun Pharmaceutical Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Anhui Topsun Pharmaceutical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Anhui Topsun Pharmaceutical Recent Developments
12.5 Chang Zhou Jialing Medicine Industry
12.5.1 Chang Zhou Jialing Medicine Industry Corporation Information
12.5.2 Chang Zhou Jialing Medicine Industry Overview
12.5.3 Chang Zhou Jialing Medicine Industry Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Chang Zhou Jialing Medicine Industry Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Chang Zhou Jialing Medicine Industry Recent Developments
12.6 Suzhou Luosen Auxiliaries
12.6.1 Suzhou Luosen Auxiliaries Corporation Information
12.6.2 Suzhou Luosen Auxiliaries Overview
12.6.3 Suzhou Luosen Auxiliaries Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Suzhou Luosen Auxiliaries Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Suzhou Luosen Auxiliaries Recent Developments
12.7 Anhui Sinotech Top Chemical
12.7.1 Anhui Sinotech Top Chemical Corporation Information
12.7.2 Anhui Sinotech Top Chemical Overview
12.7.3 Anhui Sinotech Top Chemical Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Anhui Sinotech Top Chemical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Anhui Sinotech Top Chemical Recent Developments
12.8 Yabang Group
12.8.1 Yabang Group Corporation Information
12.8.2 Yabang Group Overview
12.8.3 Yabang Group Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Yabang Group Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Yabang Group Recent Developments
12.9 Hangzhou Vanco Technology
12.9.1 Hangzhou Vanco Technology Corporation Information
12.9.2 Hangzhou Vanco Technology Overview
12.9.3 Hangzhou Vanco Technology Niclosamide Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Hangzhou Vanco Technology Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Hangzhou Vanco Technology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Niclosamide Industry Chain Analysis
13.2 Niclosamide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Niclosamide Production Mode & Process
13.4 Niclosamide Sales and Marketing
13.4.1 Niclosamide Sales Channels
13.4.2 Niclosamide Distributors
13.5 Niclosamide Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Niclosamide Industry Trends
14.2 Niclosamide Market Drivers
14.3 Niclosamide Market Challenges
14.4 Niclosamide Market Restraints
15 Key Finding in The Global Niclosamide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Niclosamide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 95% Niclosamide
Table 3. Major Manufacturers of 96%-98% Niclosamide
Table 4. Major Manufacturers of 99% Niclosamide
Table 5. Global Niclosamide Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Niclosamide Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 7. Global Niclosamide Production by Region (2017-2022) & (K MT)
Table 8. Global Niclosamide Production Market Share by Region (2017-2022)
Table 9. Global Niclosamide Production by Region (2023-2028) & (K MT)
Table 10. Global Niclosamide Production Market Share by Region (2023-2028)
Table 11. Global Niclosamide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Niclosamide Sales by Region (2017-2022) & (K MT)
Table 13. Global Niclosamide Sales Market Share by Region (2017-2022)
Table 14. Global Niclosamide Sales by Region (2023-2028) & (K MT)
Table 15. Global Niclosamide Sales Market Share by Region (2023-2028)
Table 16. Global Niclosamide Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Niclosamide Revenue Market Share by Region (2017-2022)
Table 18. Global Niclosamide Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Niclosamide Revenue Market Share by Region (2023-2028)
Table 20. Global Niclosamide Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 21. Global Niclosamide Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Niclosamide Sales by Manufacturers (2017-2022) & (K MT)
Table 23. Global Niclosamide Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Niclosamide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Niclosamide Revenue Share by Manufacturers (2017-2022)
Table 26. Niclosamide Price by Manufacturers 2017-2022 (USD/MT)
Table 27. Global Niclosamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Niclosamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Niclosamide as of 2021)
Table 29. Niclosamide Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Niclosamide Product Offered
Table 31. Date of Manufacturers Enter into Niclosamide Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Niclosamide Sales by Type (2017-2022) & (K MT)
Table 34. Global Niclosamide Sales by Type (2023-2028) & (K MT)
Table 35. Global Niclosamide Sales Share by Type (2017-2022)
Table 36. Global Niclosamide Sales Share by Type (2023-2028)
Table 37. Global Niclosamide Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Niclosamide Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Niclosamide Revenue Share by Type (2017-2022)
Table 40. Global Niclosamide Revenue Share by Type (2023-2028)
Table 41. Niclosamide Price by Type (2017-2022) & (USD/MT)
Table 42. Global Niclosamide Price Forecast by Type (2023-2028) & (USD/MT)
Table 43. Global Niclosamide Sales by Application (2017-2022) & (K MT)
Table 44. Global Niclosamide Sales by Application (2023-2028) & (K MT)
Table 45. Global Niclosamide Sales Share by Application (2017-2022)
Table 46. Global Niclosamide Sales Share by Application (2023-2028)
Table 47. Global Niclosamide Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Niclosamide Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Niclosamide Revenue Share by Application (2017-2022)
Table 50. Global Niclosamide Revenue Share by Application (2023-2028)
Table 51. Niclosamide Price by Application (2017-2022) & (USD/MT)
Table 52. Global Niclosamide Price Forecast by Application (2023-2028) & (USD/MT)
Table 53. North America Niclosamide Sales by Type (2017-2022) & (K MT)
Table 54. North America Niclosamide Sales by Type (2023-2028) & (K MT)
Table 55. North America Niclosamide Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Niclosamide Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Niclosamide Sales by Application (2017-2022) & (K MT)
Table 58. North America Niclosamide Sales by Application (2023-2028) & (K MT)
Table 59. North America Niclosamide Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Niclosamide Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Niclosamide Sales by Country (2017-2022) & (K MT)
Table 62. North America Niclosamide Sales by Country (2023-2028) & (K MT)
Table 63. North America Niclosamide Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Niclosamide Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Niclosamide Sales by Type (2017-2022) & (K MT)
Table 66. Europe Niclosamide Sales by Type (2023-2028) & (K MT)
Table 67. Europe Niclosamide Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Niclosamide Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Niclosamide Sales by Application (2017-2022) & (K MT)
Table 70. Europe Niclosamide Sales by Application (2023-2028) & (K MT)
Table 71. Europe Niclosamide Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Niclosamide Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Niclosamide Sales by Country (2017-2022) & (K MT)
Table 74. Europe Niclosamide Sales by Country (2023-2028) & (K MT)
Table 75. Europe Niclosamide Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Niclosamide Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Niclosamide Sales by Type (2017-2022) & (K MT)
Table 78. Asia Pacific Niclosamide Sales by Type (2023-2028) & (K MT)
Table 79. Asia Pacific Niclosamide Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Niclosamide Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Niclosamide Sales by Application (2017-2022) & (K MT)
Table 82. Asia Pacific Niclosamide Sales by Application (2023-2028) & (K MT)
Table 83. Asia Pacific Niclosamide Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Niclosamide Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Niclosamide Sales by Region (2017-2022) & (K MT)
Table 86. Asia Pacific Niclosamide Sales by Region (2023-2028) & (K MT)
Table 87. Asia Pacific Niclosamide Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Niclosamide Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Niclosamide Sales by Type (2017-2022) & (K MT)
Table 90. Latin America Niclosamide Sales by Type (2023-2028) & (K MT)
Table 91. Latin America Niclosamide Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Niclosamide Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Niclosamide Sales by Application (2017-2022) & (K MT)
Table 94. Latin America Niclosamide Sales by Application (2023-2028) & (K MT)
Table 95. Latin America Niclosamide Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Niclosamide Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Niclosamide Sales by Country (2017-2022) & (K MT)
Table 98. Latin America Niclosamide Sales by Country (2023-2028) & (K MT)
Table 99. Latin America Niclosamide Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Niclosamide Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Niclosamide Sales by Type (2017-2022) & (K MT)
Table 102. Middle East and Africa Niclosamide Sales by Type (2023-2028) & (K MT)
Table 103. Middle East and Africa Niclosamide Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Niclosamide Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Niclosamide Sales by Application (2017-2022) & (K MT)
Table 106. Middle East and Africa Niclosamide Sales by Application (2023-2028) & (K MT)
Table 107. Middle East and Africa Niclosamide Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Niclosamide Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Niclosamide Sales by Country (2017-2022) & (K MT)
Table 110. Middle East and Africa Niclosamide Sales by Country (2023-2028) & (K MT)
Table 111. Middle East and Africa Niclosamide Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Niclosamide Revenue by Country (2023-2028) & (US$ Million)
Table 113. Shanxi Hanjiang Pharmaceutical Corporation Information
Table 114. Shanxi Hanjiang Pharmaceutical Description and Major Businesses
Table 115. Shanxi Hanjiang Pharmaceutical Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 116. Shanxi Hanjiang Pharmaceutical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Shanxi Hanjiang Pharmaceutical Recent Development
Table 118. Zhengqing Pharmaceutical Group Corporation Information
Table 119. Zhengqing Pharmaceutical Group Description and Major Businesses
Table 120. Zhengqing Pharmaceutical Group Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 121. Zhengqing Pharmaceutical Group Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Zhengqing Pharmaceutical Group Recent Development
Table 123. Prosperity Galaxy Chemical Corporation Information
Table 124. Prosperity Galaxy Chemical Description and Major Businesses
Table 125. Prosperity Galaxy Chemical Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 126. Prosperity Galaxy Chemical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Prosperity Galaxy Chemical Recent Development
Table 128. Anhui Topsun Pharmaceutical Corporation Information
Table 129. Anhui Topsun Pharmaceutical Description and Major Businesses
Table 130. Anhui Topsun Pharmaceutical Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 131. Anhui Topsun Pharmaceutical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Anhui Topsun Pharmaceutical Recent Development
Table 133. Chang Zhou Jialing Medicine Industry Corporation Information
Table 134. Chang Zhou Jialing Medicine Industry Description and Major Businesses
Table 135. Chang Zhou Jialing Medicine Industry Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 136. Chang Zhou Jialing Medicine Industry Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Chang Zhou Jialing Medicine Industry Recent Development
Table 138. Suzhou Luosen Auxiliaries Corporation Information
Table 139. Suzhou Luosen Auxiliaries Description and Major Businesses
Table 140. Suzhou Luosen Auxiliaries Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 141. Suzhou Luosen Auxiliaries Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Suzhou Luosen Auxiliaries Recent Development
Table 143. Anhui Sinotech Top Chemical Corporation Information
Table 144. Anhui Sinotech Top Chemical Description and Major Businesses
Table 145. Anhui Sinotech Top Chemical Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 146. Anhui Sinotech Top Chemical Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Anhui Sinotech Top Chemical Recent Development
Table 148. Yabang Group Corporation Information
Table 149. Yabang Group Description and Major Businesses
Table 150. Yabang Group Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 151. Yabang Group Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Yabang Group Recent Development
Table 153. Hangzhou Vanco Technology Corporation Information
Table 154. Hangzhou Vanco Technology Description and Major Businesses
Table 155. Hangzhou Vanco Technology Niclosamide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 156. Hangzhou Vanco Technology Niclosamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Hangzhou Vanco Technology Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Niclosamide Distributors List
Table 161. Niclosamide Customers List
Table 162. Niclosamide Market Trends
Table 163. Niclosamide Market Drivers
Table 164. Niclosamide Market Challenges
Table 165. Niclosamide Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Niclosamide Product Picture
Figure 2. Global Niclosamide Market Share by Type in 2021 & 2028
Figure 3. 95% Niclosamide Product Picture
Figure 4. 96%-98% Niclosamide Product Picture
Figure 5. 99% Niclosamide Product Picture
Figure 6. Global Niclosamide Market Share by Application in 2021 & 2028
Figure 7. Feed
Figure 8. Pesticide
Figure 9. Pharmaceuticals
Figure 10. Niclosamide Report Years Considered
Figure 11. Global Niclosamide Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 12. Global Niclosamide Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Niclosamide Production Market Share by Region (2017-2022)
Figure 14. Global Niclosamide Production Market Share by Region (2023-2028)
Figure 15. Niclosamide Production Growth Rate in North America (2017-2028) & (K MT)
Figure 16. Niclosamide Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 17. Niclosamide Production Growth Rate in China (2017-2028) & (K MT)
Figure 18. Niclosamide Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 19. Global Niclosamide Sales 2017-2028 (K MT)
Figure 20. Global Niclosamide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Niclosamide Revenue 2017-2028 (US$ Million)
Figure 22. Global Niclosamide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Niclosamide Sales Market Share by Region (2017-2022)
Figure 24. Global Niclosamide Sales Market Share by Region (2023-2028)
Figure 25. North America Niclosamide Sales YoY (2017-2028) & (K MT)
Figure 26. North America Niclosamide Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Niclosamide Sales YoY (2017-2028) & (K MT)
Figure 28. Europe Niclosamide Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Niclosamide Sales YoY (2017-2028) & (K MT)
Figure 30. Asia-Pacific Niclosamide Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Niclosamide Sales YoY (2017-2028) & (K MT)
Figure 32. Latin America Niclosamide Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Niclosamide Sales YoY (2017-2028) & (K MT)
Figure 34. Middle East & Africa Niclosamide Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Niclosamide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Niclosamide in the World: Market Share by Niclosamide Revenue in 2021
Figure 37. Niclosamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Niclosamide Sales Market Share by Type (2017-2028)
Figure 39. Global Niclosamide Revenue Market Share by Type (2017-2028)
Figure 40. Global Niclosamide Sales Market Share by Application (2017-2028)
Figure 41. Global Niclosamide Revenue Market Share by Application (2017-2028)
Figure 42. North America Niclosamide Sales Market Share by Type (2017-2028)
Figure 43. North America Niclosamide Revenue Market Share by Type (2017-2028)
Figure 44. North America Niclosamide Sales Market Share by Application (2017-2028)
Figure 45. North America Niclosamide Revenue Market Share by Application (2017-2028)
Figure 46. North America Niclosamide Sales Share by Country (2017-2028)
Figure 47. North America Niclosamide Revenue Share by Country (2017-2028)
Figure 48. U.S. Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Niclosamide Sales Market Share by Type (2017-2028)
Figure 51. Europe Niclosamide Revenue Market Share by Type (2017-2028)
Figure 52. Europe Niclosamide Sales Market Share by Application (2017-2028)
Figure 53. Europe Niclosamide Revenue Market Share by Application (2017-2028)
Figure 54. Europe Niclosamide Sales Share by Country (2017-2028)
Figure 55. Europe Niclosamide Revenue Share by Country (2017-2028)
Figure 56. Germany Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 57. France Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Niclosamide Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Niclosamide Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Niclosamide Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Niclosamide Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Niclosamide Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Niclosamide Revenue Share by Region (2017-2028)
Figure 67. China Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 70. India Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 72. Taiwan Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 76. Philippines Niclosamide Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Niclosamide Sales Market Share by Type (2017-2028)
Figure 78. Latin America Niclosamide Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Niclosamide Sales Market Share by Application (2017-2028)
Figure 80. Latin America Niclosamide Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Niclosamide Sales Share by Country (2017-2028)
Figure 82. Latin America Niclosamide Revenue Share by Country (2017-2028)
Fig
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs